Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN74123635
ISRCTN74123635
Completed
Not Applicable

Intravitreal Triamcinolone with Transpupillary Thermal Therapy (TTT) for Subfoveal Choroidal Neovascularization in Age Related Macular Degeneratio

Association to Avoid Blindness (Asociación Para Evitar La Ceguera) (APEC) (Mexico)0 sites200 target enrollmentMay 16, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsAge-Related Macular Degeneration (ARMD) not available for current therapiesEye DiseasesAge-Related Macular Degeneration (ARMD)

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Age-Related Macular Degeneration (ARMD) not available for current therapies
Sponsor
Association to Avoid Blindness (Asociación Para Evitar La Ceguera) (APEC) (Mexico)
Enrollment
200
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 16, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
Association to Avoid Blindness (Asociación Para Evitar La Ceguera) (APEC) (Mexico)

Eligibility Criteria

Inclusion Criteria

  • •Patients with severe ARMD (choroidal neovascularization \[CNV]) that could not be treated with photodynamic therapy (PDT) because of bad prognosis or economical reasons.

Exclusion Criteria

  • •1\. Any patient that has indication for PDT and has the economical means to get this therapy
  • •2\. Media opacity
  • •3\. Previous treatment for CNV

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 4
The Use of Intravitreal Injection of Triamcinolone Acetonide in Diabetic Patients to Reduce Diabetic Macular EdemaDiabetic macular edemaEye - Diseases / disorders of the eye
ACTRN12613000249752suez canal university hospital19
Completed
Not Applicable
Intravitreal Injection of Triamcinolone Acetonide in Retinitis
IRCT201104266293N1Tehran University of Medical Sciences161
Completed
Phase 2
Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema that Persists after Laser Treatment (TDMO)Diabetic Macular OedemaMetabolic and Endocrine - DiabetesEye - Diseases / disorders of the eye
ACTRN12605000211662Professor Mark Gillies70
Completed
Not Applicable
Perioperative intravitreal triamcinolone in phacoemulsification for concurrent clinically significant diabetic macular oedema
ISRCTN91792333Record Provided by the NHSTCT Register - 2007 Update - Department of Health56
Active, not recruiting
Not Applicable
Triamcinolone Acetonide Intravitreal Injection for the treatment for exudative maculopathy - NDexudative maculopathyMedDRA version: 8.1Level: LLTClassification code 10038862Term: Retinal exudates
EUCTR2006-001727-19-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI